Global Organ Transplant Immunosuppressant Drugs Market Size & Outlook
Global organ transplant immunosuppressant drugs market, 2018-2030 (US$M)
Related Markets
Global organ transplant immunosuppressant drugs market highlights
- The global organ transplant immunosuppressant drugs market generated a revenue of USD 5,512.1 million in 2024 and is expected to reach USD 7,238.5 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 4.6% by 2030.
- In terms of segment, calcineurin inhibitors accounted for a revenue of USD 2,284.8 million in 2024.
- Calcineurin Inhibitors is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 5,512.1 million |
| Market revenue in 2030 | USD 7,238.5 million |
| Growth rate | 4.6% (CAGR from 2025 to 2030) |
| Largest segment | Calcineurin inhibitors |
| Fastest growing segment | Calcineurin Inhibitors |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Calcineurin Inhibitors, Antiproliferative Agents, MTOR Inhibitor, Steroids, Other Drug Classes |
Other key industry trends
- In terms of revenue, the North America accounted for 40.0% of the global organ transplant immunosuppressant drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 456.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Organ Transplant Immunosuppressant Drugs Market Scope
Organ Transplant Immunosuppressant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global organ transplant immunosuppressant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to organ transplant immunosuppressant drugs market will help companies and investors design strategic landscapes.
Calcineurin inhibitors was the largest segment with a revenue share of 41.45% in 2024. Horizon Databook has segmented the Global organ transplant immunosuppressant drugs market based on calcineurin inhibitors, antiproliferative agents, mtor inhibitor, steroids, other drug classes covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Organ Transplant Immunosuppressant Drugs Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Other Drug Classes
- Global Organ Transplant Immunosuppressant Drugs Transplant Outlook (Revenue, USD Million, 2018-2030)
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Other
Reasons to subscribe to Global organ transplant immunosuppressant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global organ transplant immunosuppressant drugs market databook
-
Our clientele includes a mix of organ transplant immunosuppressant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global organ transplant immunosuppressant drugs market, including forecasts for subscribers. This global databook contains high-level insights into Global organ transplant immunosuppressant drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global organ transplant immunosuppressant drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Organ transplant immunosuppressant drugs market size, 2024 (US$M)
Global organ transplant immunosuppressant drugs market share, by drug class, 2024 & 2030 (%, US$M)
Organ transplant immunosuppressant drugs market: Opportunity assessment by country
Global organ transplant immunosuppressant drugs market, by region, 2024 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
